Know Labs (NYSEAMERICAN:KNW) Shares Up 3.8% – What’s Next?

Know Labs, Inc. (NYSEAMERICAN:KNW)’s stock price shot up 3.8% during trading on Friday . The stock traded as high as $2.17 and last traded at $2.1390. 612,050 shares were traded during trading, an increase of 60% from the average session volume of 381,756 shares. The stock had previously closed at $2.06.

Know Labs Trading Up 3.8%

The company’s 50-day moving average is $2.14 and its two-hundred day moving average is $2.33. The firm has a market cap of $16.04 million, a P/E ratio of -0.33 and a beta of 1.83.

Hedge Funds Weigh In On Know Labs

A number of hedge funds have recently bought and sold shares of the company. Cerity Partners LLC purchased a new stake in shares of Know Labs in the second quarter valued at about $158,000. Corient Private Wealth LLC bought a new stake in Know Labs in the 2nd quarter worth about $99,000. Bard Financial Services Inc. bought a new stake in Know Labs in the 3rd quarter worth about $80,000. Finally, United Capital Management of KS Inc. purchased a new stake in Know Labs in the 2nd quarter valued at about $49,000. 23.96% of the stock is owned by hedge funds and other institutional investors.

About Know Labs

Know Labs, Inc (NYSE American: KNW) is a life sciences company developing non‐invasive sensing solutions based on its proprietary Bio‐RFID platform. The technology employs low‐power radio‐frequency spectroscopy to scan the skin, enabling the detection of biochemical markers such as blood glucose, hydration levels and alcohol concentration without the need for blood draws or fingersticks. By applying sophisticated signal‐processing algorithms to reflected electromagnetic waves, the company aims to deliver real‐time, continuous monitoring devices that could transform standard practices in healthcare and wellness.

The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways.